65,437 trials
Oral Hygiene
Primary: Change From Baseline in Mean Total Modified Lobene Stain Index (MLSI) Score at Week 8 — -2.33; -2.42; -0.38 score on a scale — p=<0.0001
Cerebral Ischemia · Cardiac Arrest
Primary: % of Ischaemic Voxels With an ADC<0.65 mm2/s on Day 4-5 (Diffusion Weighted MRI) — 10.6; 11.0 percentage of ischaemic voxels — p=0.0881
Metastatic Castration-resistant Prostate Cancer
Primary: Number of Participants With Adverse Events (AE) and Serious Adverse Events (SAE) — 14; 15; 13; 7 Participants
Adherence, Medication · Transplantation, Kidney
Primary: Number of Kidney Transplant Patients Who Expressed an Understanding of the Term Immunosuppression Medication Adherence and the Importance Immunosuppression Medication…
Skin Lesion · Skin Abnormalities · Sebaceous Hyperplasia
Primary: Total Number of Cleared SH Lesions — 99.5 Percentage of cleared SH Lesions
Chronic Low-back Pain · Hip Impairments · Hip-spine Syndrome
Primary: Quebec Back Pain Disability Scale — 27.9; 27.9; 16.7; 20.3 score on a scale
Rett Syndrome
Primary: Percentage of Subjects With Treatment-emergent Adverse Events (TEAEs), Percentage of Subjects With Serious Adverse Events (SAEs), and Percentage of Subjects With…
PreDiabetes
Primary: Percent Weight Change — -8.13; -3.46 percent change — p=<0.0001
Pain
Primary: Time Weighted Sum of Pain Intensity Difference Score From Baseline (0 Hour) to 12 Hours (SPID 0-12) — 5.59; 37.08; 46.98; 52.45 Units on a scale — p=<0.001
Pulmonary Tuberculosis
Primary: Average Change Per Day (Slope) of Log Colony Forming Units (CFU) Counts From Day 0 to Day 14 (BACFU [0-14]) to Assess Bactericidal Activity — -0.039; -0.086; -0.065…
Head and Neck Cancer · Lymphedema · Fibrosis
Primary: Feasibility of the LEF-SCP (Self-Care Skill Training Sessions) — 20; 18 Participants
Coronavirus Disease 2019
Primary: Changes From Baseline in Daily COVID-19-related Symptom Severity Score Through Day 56. — -16.3; -8.1 units on a scale
Parkinson's Disease
Primary: Change in Score on the Part III Subscale of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) — 2.1; 4.2; -0.8; 3.9 Score on a scale…
Intermittent Claudication · Peripheral Vascular Diseases
Primary: Difference in the Absolute Walking Distance (AWD) at 3 Months Between the Two Treatment Groups — 220.12; 242.97; 327.74; 370.38 Meters — p=0.28
Rabies · Rabies Immunisation
Primary: Number and Percentage of Participants With Solicited Injection Site Reactogenicity Events in Each Treatment Arm and Overall — 3; 2; 0; 0 Participants